Helen Martin - OrganiGram Holdings President

OGI Stock  CAD 2.19  0.04  1.86%   

President

Helen Martin is Senior Vice President, Strategic, Legal Affairs Corporate Secretary of OrganiGram Holdings since 2019.
Age 46
Tenure 5 years
Address 145 King Street West, Toronto, ON, Canada, M5H 1J8
Phone855-961-9420
Webhttps://www.organigram.ca

OrganiGram Holdings Management Efficiency

The company has return on total asset (ROA) of (0.0556) % which means that it has lost $0.0556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5453) %, meaning that it generated substantial loss on money invested by shareholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.08. As of the 25th of November 2024, Intangibles To Total Assets is likely to grow to 0.10, while Total Assets are likely to drop about 251.2 M.
OrganiGram Holdings has accumulated 4.72 M in total debt with debt to equity ratio (D/E) of 0.28, which may suggest the company is not taking enough advantage from borrowing. OrganiGram Holdings has a current ratio of 5.05, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist OrganiGram Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, OrganiGram Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OrganiGram Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OrganiGram to invest in growth at high rates of return. When we think about OrganiGram Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Richard YoungMaple Leaf Foods
N/A
Stephen ElmerMaple Leaf Foods
N/A
Terri BurmeisterQuisitive Technology Solutions
N/A
Donald WhittyCalian Technologies
N/A
Derek ClarkCalian Technologies
N/A
Andre KhachatouriansFiran Technology Group
N/A
Dennis OrganMaple Leaf Foods
50
Jordan CoplandQuorum Information Technologies
N/A
Patrick TheraCalian Technologies
N/A
Adam GroganMaple Leaf Foods
N/A
Rene McleanMaple Leaf Foods
N/A
Randall HuffmanMaple Leaf Foods
N/A
Ian HenryMaple Leaf Foods
N/A
Curtis FrankMaple Leaf Foods
N/A
Rocco CappuccittiMaple Leaf Foods
N/A
Robert QuirionQuorum Information Technologies
N/A
Bentley BrooksMaple Leaf Foods
N/A
Michael RawleMaple Leaf Foods
N/A
Lynda KuhnMaple Leaf Foods
N/A
Glen GrattonMaple Leaf Foods
N/A
Jacqueline GauthierCalian Technologies
N/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. ORGANIGRAM HOLDINGS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 474 people. OrganiGram Holdings (OGI) is traded on Toronto Exchange in Canada and employs 914 people. OrganiGram Holdings is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

OrganiGram Holdings Leadership Team

Elected by the shareholders, the OrganiGram Holdings' board of directors comprises two types of representatives: OrganiGram Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OrganiGram. The board's role is to monitor OrganiGram Holdings' management team and ensure that shareholders' interests are well served. OrganiGram Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OrganiGram Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Derrick West, Chief Financial Officer
CPA CPA, Chief Officer
Beena Goldenberg, CEO Director
Helen Martin, Senior Vice President, Strategic, Legal Affairs Corporate Secretary
Katrina McFadden, Chief Officer
Raymond Gracewood, Senior Vice President of Marketing and Communications
Megan McCrae, Senior Communications
Amy Schwalm, Vice President of Investor Relations
Matthew Rogers, Vice President - Operations
CFA CA, Chief Officer
Paolo Luca, Chief Financial Officer
Julie Chamberlain, Vice President of Marketing
Tina Shannon, VP HR
Peter Amirault, Independent Chairman of the Board
Nathalie Batten, Senior Operations
Timothy Emberg, Senior Vice President - Sales and Commercial Operations
Gregory Engel, Chief Executive Officer, Director
Cameron Bishop, Vice President of Public Affairs and Stakeholder Relations
Dexter John, Independent Director
Geoff Riggs, Chief Officer
Sherry Porter, Independent Director
Max Schwartz, Director Relations
Jeffrey Purcell, Senior Vice President - Operations Services

OrganiGram Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OrganiGram Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with OrganiGram Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OrganiGram Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against OrganiGram Stock

  0.75BNS Bank of Nova Scotia Earnings Call Next WeekPairCorr
  0.64AMZN Amazon CDRPairCorr
  0.56BMO Bank of MontrealPairCorr
  0.55RY Royal BankPairCorr
  0.54TD-PFI Toronto Dominion BankPairCorr
The ability to find closely correlated positions to OrganiGram Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OrganiGram Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OrganiGram Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OrganiGram Holdings to buy it.
The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OrganiGram Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OrganiGram Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OrganiGram Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.